Of interest, in studies of calcineurin function in the pathogenesis of cardiac hypertrophy, calcineurin activity has been shown to be reduced by MAFbx, FOXO1 or FOXO3A, and to be directly linked to myocardiocyte size [17,36]. This evidence concerns the gene FOXO1 and cardiac hypertrophy.